The following is a summary of “Lipid abnormality in diabetic kidney disease and potential treatment advancements,” published ...

Arrowhead Pharmaceuticals, Inc. shines with 19 clinical programs, strategic partnerships, and promising RNAi data. Click for ...

Doctors and experts gathered late last year in Bonifacio Global City to raise awareness on a “silent epidemic” that is ...

Having any sleep disorder is associated with an increased risk for aortic stenosis, according to an analysis of data from two large sets of electronic health records.

A new study shows that giving clinicians access to point-of-care testing for lipid levels increased rates of screening during ...

Patients with vitiligo who received long-term NBUVB phototherapy vs no phototherapy were associated with reduced risks for cardiometabolic diseases.

Obstructive sleep apnea (OSA) and metabolic syndrome (MetS) are increasingly recognized as interrelated conditions with significant implications for ...

India, with over 101 million diabetes patients and rising obesity rates, faces a critical need for effective treatment ...

The much-awaited launch of Mounjaro, an injectable drug used to treat obesity, overweight, and type 2 diabetes, has been ...

Eli Lilly and Company (India) on Thursday said it has launched a first-of-its-kind medication for obesity and type 2 diabetes ...

FibroScan overestimated advanced fibrosis and cirrhosis in patients with class 3 obesity and metabolic dysfunction-associated steatotic liver disease.